Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register

NCT07437157 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT07437157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07437157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Recruiting
Start date
June 11, 2025
Completion date
February 28, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated steatotic liver disease, type 2 diabetes (t2dm)